Pfizer Changes Costly Cardiac Drugs’ Access Rules for 340B Providers
Drug manufacturer Pfizer is changing how healthcare providers access 340B pricing on two expensive, related heart medicines, effective Nov. 1, [...]
*Sign up for news summaries and alerts from 340B Report